THYROID CARCINOMA-ASSOCIATED GENETIC MUTATIONS ALSO OCCUR IN THYROID LYMPHOMAS

Molecular testing for mutations activating the mitogen-associated protein kinase signaling pathway is being used to help diagnose thyroid carcinomas. However, the prevalence of these mutations in thyroid lymphomas has not been reported. Therefore, we studied the prevalence of BRAF, NRAS, HRAS, and K...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Aggarwal, Nidhi, Swerdlow, Steven H., Kelly, Lindsey M., Ogilvie, Jennifer B., Nikiforova, Mariana N., Sathanoori, Malini, Nikiforov, Yuri E.
Format: Artigo
Idioma:Inglês
Publicat: 2012
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3434253/
https://ncbi.nlm.nih.gov/pubmed/22575864
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/modpathol.2012.73
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars